Bamlanivimab alone with the U.S. government and is focusing on supply of bamlanivimab and etesevimab together
The Pharma Data
APRIL 14, 2021
Lilly scientists rapidly developed the antibody in less than three months after it was discovered by AbCellera and the scientists at the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center. volunteers to evaluate the safety, tolerability, pharmacokinetics and immunogenicity.
Let's personalize your content